Anaemia in inflammatory rheumatic diseases (Q38059457)

28 August 2017

Anaemia in inflammatory rheumatic diseases (English)

1 reference

28 August 2017

0 references

2

Georg Schett

1 reference

28 August 2017

Günter Weiss

1

1 reference

PubMed ID

23147894

28 August 2017

language of work or name

English

0 references

publication date

13 November 2012

1 reference

Nature Reviews Rheumatology

28 August 2017

1 reference

28 August 2017

9

1 reference

28 August 2017

4

1 reference

28 August 2017

205-215

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2012.183

28 August 2017

0 references

cites work

The pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Anemia: not just an innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Proinflammatory state, hepcidin, and anemia in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive am

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Genetic mechanisms and modifying factors in hereditary hemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

The anemia of familial Mediterranean fever disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron, anaemia, and inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron metabolism in the anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepcidin and iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Two to tango: regulation of Mammalian iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Cytokine-mediated regulation of iron transport in human monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Role of IL-10 for induction of anemia during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Anemia of chronic disease: pathophysiology and laboratory diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Pure red cell aplasia and lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Clinical assessment and management of cytopenias in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in Hepatitis B surface antigen-negative cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Ferritin, iron homeostasis, and oxidative damage1,2 1Guest Editor: Mario Comporti 2This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Detection, evaluation, and management of iron-restricted erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron Deficiency and Erythropoiesis: New Diagnostic Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron loading and disease surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

The struggle for iron - a metal at the host-pathogen interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron and microbial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron overload alters innate and T helper cell responses to Candida albicans in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Role of interleukin-6 in the anemia of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Liberal or restrictive transfusion in high-risk patients after hip surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron and the anaemia of chronic disease: a review and strategic recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Ferric carboxymaltose in patients with heart failure and iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Autocrine formation of hepcidin induces iron retention in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Genes determining blood cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Effect of transfusional iron overload on immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Hepcidin regulation by innate immune and infectious stimuli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Interferon-gamma induced nitric oxide-mediated apoptosis of anemia of chronic disease in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: the effect of oral prednisolone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Proinflammatory cytokines lowering erythropoietin production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Iron levels in polarized macrophages: regulation of immunity and autoimmunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Indications for red cell transfusion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease-A Randomized, Controlled, Open-Label, Multicenter Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Effects of intravenous iron saccharate on improving severe anemia in rheumatoid arthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

New and old players in the hepcidin pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.183

Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells.

31 March 2020

1 reference

12 December 2020

Ferritin, iron homeostasis, and oxidative damage

1 reference

12 December 2020

Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.

1 reference

12 December 2020

Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia

1 reference

12 December 2020

Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.

1 reference

12 December 2020

Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia

1 reference

12 December 2020

Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice

1 reference

12 December 2020

Association of anemia and physical disability among patients with rheumatoid arthritis.

1 reference

12 December 2020

Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis

1 reference

12 December 2020

Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin

1 reference

12 December 2020

Anemia and renal function in patients with rheumatoid arthritis.

1 reference

12 December 2020

The anemia of chronic disorders

1 reference

12 December 2020

Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis

1 reference

12 December 2020

Anemia of chronic disorders in systemic autoimmune diseases

1 reference

12 December 2020

Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2012.183

1 reference

PubMed ID

23147894

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23147894